SFPQ

Splicing factor, proline- and glutamine-rich · P23246 · SFPQ on Sugi Atlas →

0 patent compounds predicted against SFPQ, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SFPQ by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer PHASE2COMPLETED
Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) PHASE1/PHASE2SUSPENDED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
Molecular Disease Profile of Hematological Malignancies nanUNKNOWN
Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping nanUNKNOWN
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Identification and Characterization of Novel Non-Coding Variants That Contribute to Genetic Disorders nanCOMPLETED
SRSF2 Gene Mutation in Patients With t-MDS/AML nanCOMPLETED
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
RNA Sequencing in the Framingham Heart Study Third Generation Cohort Exam 2 nanCOMPLETED
Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF) nanCOMPLETED
Transcriptomic Profile of Patients Treated With Different Modalities of Spinal Cord Stimulation nanUNKNOWN
Mesenchymal Stem Cells in NPM1 Mutated Low Risk Acute Myeloid Leukemia: a Study of the Tumor Microenvironment and Its Contribution to the Outcome nanCOMPLETED
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma nanACTIVE_NOT_RECRUITING
Clinical Study of Spinal Muscular Atrophy nanCOMPLETED
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases nanRECRUITING
Brain Involvement in Myotonic Dystrophy Type I: From Functional Neuroimaging to the Impact on Quality of Life nanCOMPLETED
Establishment of Human Cellular Disease Models for Wilson Disease nanCOMPLETED
Research on Effects of Acute Consumption of Nuts in Obese Diabetic Women nanRECRUITING
Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SFPQ binder may also engage these)

ProteinNameSimilarity
Q8VIJ6 1.000 Q8VIJ6 →
PSPC1 Paraspeckle component 1 0.990 landscape →
Q6NWC6 0.989 Q6NWC6 →
Q1LZD9 0.989 Q1LZD9 →
Q4KLH4 0.989 Q4KLH4 →
Q63627 0.988 Q63627 →
Q0P5D2 0.988 Q0P5D2 →
Q6DDW4 0.988 Q6DDW4 →
Q1JPY8 0.988 Q1JPY8 →
Q5NVH8 0.987 Q5NVH8 →
Q9GRX4 0.987 Q9GRX4 →
Q6NVF9 0.987 Q6NVF9 →
Q5ZK88 0.986 Q5ZK88 →
CPSF6 Cleavage and polyadenylation specificity factor subunit 6 0.985 landscape →
Q9GRW7 0.985 Q9GRW7 →
Q5ZL34 0.985 Q5ZL34 →
O95104 0.984 O95104 →
Q5RFL9 0.984 Q5RFL9 →
Q04047 0.984 Q04047 →
Q0DA50 0.983 Q0DA50 →
Q8R326 0.983 Q8R326 →
Q9VSH4 0.982 Q9VSH4 →
Q9VIV2 0.982 Q9VIV2 →
PPP1R10 Serine/threonine-protein phosphatase 1 regulatory subunit 10 0.982 landscape →
Q767K9 0.982 Q767K9 →
Q8CGF7 0.981 Q8CGF7 →
A9LNK9 0.981 A9LNK9 →
Q5TM61 0.981 Q5TM61 →
Q960X8 0.980 Q960X8 →
Q21955 0.980 Q21955 →